Log in
Enquire now
‌

US Patent 11421003 FimH mutant, compositions therewith and use thereof

Patent 11421003 was granted and assigned to Janssen Pharmaceuticals on August, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Janssen Pharmaceuticals
Janssen Pharmaceuticals
Current Assignee
Janssen Pharmaceuticals
Janssen Pharmaceuticals
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11421003
Date of Patent
August 23, 2022
Patent Application Number
17150025
Date Filed
January 15, 2021
Patent Citations Received
‌
US Patent 12012435 FimH mutant, compositions therewith and use thereof
0
Patent Primary Examiner
‌
Sarvamangala Devi

Polypeptides comprising a FimH lectin domain comprising an amino acid mutation that causes the FimH lectin domain to be in the low affinity conformation for mannose are described. Pharmaceutical compositions which comprise such polypeptides and methods of stimulating an immune response in a subject in need thereof by administration of the polypeptide are further described.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11421003 FimH mutant, compositions therewith and use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.